BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28709531)

  • 1. Bone Margin Analysis for Osteonecrosis and Osteomyelitis of the Jaws.
    Qaisi M; Montague L
    Oral Maxillofac Surg Clin North Am; 2017 Aug; 29(3):301-313. PubMed ID: 28709531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
    J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease.
    Marx RE; Tursun R
    Int J Oral Maxillofac Surg; 2012 Mar; 41(3):283-9. PubMed ID: 22244079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
    Li YF; Hu J
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
    [No Abstract]   [Full Text] [Related]  

  • 5. A commentary on "Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral Maxillofac. Surg. 41 (2012) 283-289].
    Kalmar JR
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):147-8. PubMed ID: 23107998
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to - a commentary on "Suppurative osteomyelitis, bisphosphonate induced 1 osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its 2 implications for the mechanism of each disease" by R.E. Marx and R. Tursun [Int. J. Oral. Maxillofac. Surg. 41 (3) (2012) 283-289].
    Marx RE; Tursun R
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):148-9. PubMed ID: 23219001
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
    J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
    Shuster A; Reiser V; Trejo L; Ianculovici C; Kleinman S; Kaplan I
    Int J Oral Maxillofac Surg; 2019 Jan; 48(1):17-22. PubMed ID: 30054185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
    Yfanti Z; Tetradis S; Nikitakis NG; Alexiou KE; Makris N; Angelopoulos C; Tsiklakis K
    Eur J Radiol; 2023 Aug; 165():110916. PubMed ID: 37300936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: A comparative histopathological study.
    De Antoni CC; Matsumoto MA; Silva AAD; Curi MM; Santiago Júnior JF; Sassi LM; Cardoso CL
    Braz Oral Res; 2018; 32():e23. PubMed ID: 29723337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraparesis after surgical treatment of bisphosphonate-associated osteonecrosis of the jaw.
    Zaami S; Busardò FP; Amatruda A; Ricci G; Esposito V
    J Neurosurg Sci; 2018 Feb; 62(1):97-99. PubMed ID: 27057695
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk Factors for Infection Recurrence After Surgical Resection of Advanced Stage Osteonecrosis of the Mandible.
    Doub JB; Kang A; Lee C; Dyalram D; Shih P; Twaddell WS; Lubek JE
    J Oral Maxillofac Surg; 2024 Mar; 82(3):332-340. PubMed ID: 38199239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT.
    Yfanti Z; Tetradis S; Nikitakis NG; Eleni Alexiou K; Makris N; Angelopoulos C; Tsiklakis K
    Eur J Radiol; 2024 Apr; 173():111387. PubMed ID: 38428257
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of osteonecrosis of the jaws induced by radiotherapy in oncological patients: preliminary results.
    Manzon L; Rossi E; Fratto G
    Eur Rev Med Pharmacol Sci; 2015; 19(2):194-200. PubMed ID: 25683930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor regarding "Radiologic findings of osteonecrosis, osteoradionecrosis, osteomyelitis and jaw metastatic disease with cone beam CT".
    Yilmaz B; Topkan E
    Eur J Radiol; 2023 Nov; 168():111123. PubMed ID: 37806191
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
    Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SPECT/CT in the assessment of inflammatory jaw pathologies.
    Modabber A; Schick D; Möhlhenrich SC; Mottaghy FM; Verburg FA; Hölzle F; Gerressen M
    Eur J Radiol; 2020 Apr; 125():108917. PubMed ID: 32120276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
    Hansen T; Kunkel M; Weber A; James Kirkpatrick C
    J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y; Ogura I
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.
    Stockmann P; Wehrhan F; Schwarz-Furlan S; Stelzle F; Trabert S; Neukam FW; Nkenke E
    J Transl Med; 2011 Aug; 9():135. PubMed ID: 21843332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.